Is a prostate volume of 33 cc normal for a 68‑year‑old male?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is a Prostate Volume of 33 cc Normal for a 68-Year-Old Man?

Yes, a prostate volume of 33 cc is within the normal range for a 68-year-old man, though it represents the upper end of normal and warrants monitoring for progression.

Understanding Normal Prostate Volume at Age 68

A 33 cc prostate in a 68-year-old falls within established reference ranges from multiple population studies:

  • Korean population data 1 shows mean prostate volumes of 27.7 g in men in their 60s and 31 g in men in their 70s, placing 33 cc right at the expected range for this age group
  • German community data 2 demonstrates mean prostate volume increases from 24 cc at age 50 to 38 cc by age 80, with 33 cc falling comfortably within the normal distribution for the late 60s age range
  • UK Biobank imaging study 3 of over 30,000 men confirms continuous prostate volume increase with age, with 33 cc being typical for this age bracket

Clinical Significance of This Volume

The 30 cc threshold matters clinically. While 33 cc is normal for age, it crosses an important clinical decision point:

  • Prostates >30 cc respond better to combination therapy with 5-alpha reductase inhibitors (5ARIs) plus alpha blockers if lower urinary tract symptoms develop 4
  • This volume predicts higher risk of symptom progression and benign prostatic obstruction-related complications over time 5
  • Men with prostates >30 cc have increased risk of acute urinary retention and may benefit from earlier medical intervention if symptomatic

What This Means for Monitoring

For a 68-year-old with a 33 cc prostate, focus on:

  • PSA correlation: At this prostate volume, expect PSA levels around 1.5-2.5 ng/mL based on age-adjusted norms 1, 2. PSA scales with prostate volume in an age-dependent manner 3
  • Annual growth rate: Expect approximately 0.5-1.0 mL/year growth 6. Faster growth warrants closer surveillance
  • Symptom assessment: Use International Prostate Symptom Score (IPSS) to quantify any lower urinary tract symptoms, as larger prostates correlate with higher symptom burden 1

Key Clinical Pitfalls to Avoid

Don't assume normal volume equals no pathology. The evidence shows:

  • Prostate cancer can occur at any prostate size; volume doesn't exclude malignancy 7, 8
  • PSA should still be interpreted in context of prostate volume (PSA density = PSA/prostate volume) 9
  • Digital rectal examination remains important regardless of volume, as it can detect abnormalities missed by PSA alone 5, 4

Don't ignore the trajectory. A single measurement of 33 cc is less informative than the rate of change. If this represents rapid growth from a smaller baseline, it warrants more aggressive monitoring 6.

Practical Management Algorithm

For this 68-year-old with 33 cc prostate:

  1. If asymptomatic: Continue routine PSA screening every 1-2 years if PSA ≥1 ng/mL 7, 10. Consider extending to 2-4 years if PSA <1 ng/mL
  2. If symptomatic (IPSS >7): Consider alpha blocker as initial therapy; given prostate >30 cc, add 5ARI for combination therapy if inadequate response 4
  3. Monitor for progression: Repeat prostate volume measurement in 1-2 years to establish growth rate 6
  4. Red flags requiring urologic referral: PSA >4.0 ng/mL, abnormal digital rectal examination, PSA velocity >0.75 ng/mL/year, or acute urinary retention 11, 12

The bottom line: 33 cc is age-appropriate and normal, but this patient sits at a clinical threshold where proactive monitoring and early intervention for symptoms becomes more important than in men with smaller prostates.

References

Guideline

nccn clinical practice guidelines prostate cancer early detection, version 2.2015.

Journal of the National Comprehensive Cancer Network : JNCCN, 2015

Guideline

testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2018

Related Questions

What are the possible causes of a 28-year-old man's lower‑leg venous symptoms and poor circulation, and should he be referred to a vascular specialist for evaluation?
In a 30-year-old woman with a resolved 10‑day headache who now has intermittent right iliac fossa abdominal pain after travel, without fever, nausea, vomiting, diarrhea, or urinary symptoms, what is the recommended evaluation and management?
Should a postero‑anterior and lateral chest radiograph be obtained for a 10 mm nodular opacity in the left upper lung to differentiate a solitary nodule from a confluence of shadows?
How many ampoules of a 17.7% sodium solution are needed to prepare a 3% hypertonic sodium solution?
In a 41-year-old male with bilateral foot and left‑hand joint pain, morning stiffness, and fatigue, should pain be managed with an oral nonsteroidal anti‑inflammatory drug (NSAID) pill or a topical NSAID gel?
What does a ferritin level of 1037 µg/L with normal iron studies indicate and how should it be evaluated?
What is the clinical significance of calcium oxalate crystals in the urine of a patient presenting with urinary tract infection symptoms but a sterile urine culture?
Should a 2½‑year‑old child with adenovirus infection on day five, whose fever is improving but who now has profuse thick rhinorrhea and otalgia, be re‑evaluated?
What is the appropriate duration of proton pump inhibitor (PPI) therapy and tapering strategy for patients?
How should generalized pruritus without a visible rash be evaluated and managed?
In amyloidosis, what are the typical laboratory findings for serum free kappa and lambda light chains, immunoglobulin G, A, and M levels, and immunofixation results?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.